MITOTOX

Drug

D0332 | Clove oil

Molecular Formula	C7H12ClN3O2
Molecular Weight	205.64
Structure
State	liquid
Route of elimination	In a pharmacokinetic study, the metabolism of eugenol (the primary constituent of clove oil) was investigated in healthy male and female volunteers. It was quickly absorbed and metabolized after oral administration and was almost completely excreted in the urine within 24 hours of ingestion [A33147].
Half life	In a pharmacokinetic study, average half-life values of eugenol in plasma and blood were long (14.0 and 18.3 h, respectively), suggesting a potential accumulation of the drug following repeated administrations [A33137].
Absorption	Clove oil is rapidly absorbed through the skin and is used in patented systems for dermal drug delivery to enhance drug uptake from skin patch delivery systems [F108].

(R)-Methyl 2-amino-3-(1H-imidazol-4-yl)propanoate hydrochloride	92742-29-5	AKOS022184699
AS-57594	CHEMBL1222273	CTK5E7322
D-HISTIDINE METHYL ESTER HYDROCHLORIDE	D-Histidine Methyl Ester Monohydrochloride	D-Histidine methyl ester, HCl
FT-0623991	KS-00000Y6I	KSC647G2F
METHYL (2R)-2-AMINO-3-(1H-IMIDAZOL-4-YL)PROPANOATE HYDROCHLORIDE	RTR-025351	SCHEMBL4389612
VEEIFXWJNCAVEQ-FYZOBXCZSA-N